Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0B585 | ISIN: FR0004180578 | Ticker-Symbol: 9RS
Tradegate
24.01.25
10:58 Uhr
34,550 Euro
-0,450
-1,29 %
Branche
IT-Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
SWORD GROUP SE Chart 1 Jahr
5-Tage-Chart
SWORD GROUP SE 5-Tage-Chart
RealtimeGeldBriefZeit
34,60035,40024.01.
34,85035,15024.01.
GlobeNewswire (Europe)
181 Leser
Artikel bewerten:
(1)

Sword Group: Results for the fourth quarter 2024

Finanznachrichten News

Consolidated Revenue: €84.4m
Organic Growth: +17.1% (i)
EBITDA Margin: 12.0%
Net cash position up by +€20m (ii)
Record increase in backlog: +€78m
Successful transition to Artificial Intelligence

(i) on a like-for-like basis - (ii) excluding IFRS 16 & including treasury shares

KEY FIGURES
For the 4th quarter of 2024, consolidated revenue is €84.4m and EBITDA margin is 12.0%, or € 10.1m.
At 31 December 2024, consolidated revenue is €323.0m and EBITDA margin is 12.0%, or €38.8m.
Net cash (excluding IFRS 16 and including treasury shares) increased from €2.2m at 30/09/2024 to €17.8m at 31 December 2024.

Q4 2024 ACCOUNTS

Q4 | non audited figures
€m20242023
Revenue 84.4 71.5
EBITDA 10.1 8.5
EBITDA Margin 12.0% 12.0%

Organic growth on a like-for-like basis in the 4th quarter is +17.1%.

2024 ANNUAL ACCOUNTS

Année | non audited figures
€m20242023
Revenue323.0288.1
EBITDA38.834.8
EBITDA Margin12.0%12.1%

Like-for-like organic growth for 2024 is +15.9%.

ANALYSIS
The 4th quarter of 2024 was characterised by solid results, with sustained performances in terms of growth, profitability, cash flow and an increase in the backlog.
Cash generation was strong in the final quarter of 2024, rising from -€2.2m at 30/09/2024 to €17.8m at 31 December 2024 (these figures include treasury shares). Net cash has increased by €20m in 3 months.
Between 30 September and 31 December, the backlog increased significantly by €78.4m, providing visibility equivalent to 21 months of the forecast budget for 2025.

DEVELOPMENT OF OUR AI STRATEGY
At the beginning of 2024, Sword had 3 strategic axes with regard to Artificial Intelligence:
1. Increase productivity for its development activities
The first objective has now been achieved on our Barcelona and Glasgow platforms, and is currently being implemented on our Athens and Geneva platforms.
At the end of this phase, we will be using the software components produced to meet this objective in all our units.
Today, in the development phase, we are targeting a 15% increase in productivity.
2. Developing marketable expertise for our customers
In partnership with leading software publishers, Sword's teams have developed a range of offerings for key sectors: Energy, Health, Sport and Governments.
3. Direct use of AI technologies in our internal management
We have created a structure, mentioned in the new organisation chart, which includes:
- A CAIO, in charge of Artificial Intelligence,
- A CISO, in charge of Security,
- A CSO, in charge of Sustainability,
- An IEO, in charge of Efficiency.

We now have an objective to improve our internal management based on AI, which will be completed during 2025.

Our advances in the field of Artificial Intelligence will be the subject of a detailed presentation at the SFA meeting.

OUTLOOK
The Group confirms its 2028 Business Plan including:
Growth based on:
- Double-digit organic growth,
- Targeted micro-acquisitions,
- Acquisitions on a larger scale.
New strategic challenges in 3 areas:
- Artificial intelligence,
- Cybersecurity,
- Sustainability.
A programme dedicated to optimising internal management.

AGENDA
The annual financial meeting to present the Results 2024 and Outlook 2025 and beyond will be held on 12 March in Paris.
Register

Sword Group

Sword has 3,200+ IT/Digital specialists active in 50+ countries to accompany you in the growth of your organisation in the digital age.

As a leader in technological and digital transformation, Sword has a solid reputation in complex IT & business project management.

Sword optimises your processes and enhances your data.

Attachment

  • SwordGroup_Results Q42024 23012025FV (https://ml-eu.globenewswire.com/Resource/Download/5368a46a-c22a-4c84-b5b7-3cf0fb72e7d8)

© 2025 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.